Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment

Ákos Hunya, István Földi, Viktor Szegedi, K. Soós, Márta Zarándi, Antal Szabó, Dénes Zádori, B. Penke, Zsolt L. Datki

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Alpha-synuclein (αSN) plays a major role in numerous neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Intracellular inclusions containing aggregated αSN have been reported in Alzheimer's and Parkinson's affected brains. Moreover, a proteolytic fragment of αSN, the so-called non-amyloid component of Alzheimer's disease amyloid (NAC) was found to be an integral part of Alzheimer's dementia related plaques. Despite the extensive research on this topic, the exact toxic mechanism of αSN remains elusive. We have taken the advantage of an αSN overexpressing SH-SY5Y cell line and investigated the effects of classical apoptotic factors (e.g. H2O2, amphotericin B and ruthenium red) and aggregated disease-related peptides on cell viability compared to wild type neuroblastoma cells. It was found that αSN overexpressing cells are more sensitive to aggregated peptides treatment than normal expressing counterparts. In contrast, cells containing elevated amount of αSN were less vulnerable to classical apoptotic stressors than wild type cells. In addition, αSN overexpression is accompanied by altered phenotype, attenuated proliferation kinetics, increased neurite arborisation and decreased cell motility. Based on these results, the αSN overexpressing cell lines may represent a good and effective in vitro model for Alzheimer's and Parkinson's disease.

Original languageEnglish
Pages (from-to)648-654
Number of pages7
JournalBrain Research Bulletin
Volume75
Issue number5
DOIs
Publication statusPublished - Mar 28 2008

Fingerprint

Synucleins
alpha-Synuclein
Neuroblastoma
Alzheimer Disease
Parkinson Disease
Ruthenium Red
Cell Line
Peptides
Poisons
Amphotericin B
Neurites
Amyloid
Neurodegenerative Diseases
Cell Movement
Cell Survival
Phenotype

Keywords

  • Alpha-synuclein
  • Alzheimer's disease
  • Beta-amyloid
  • NAC
  • Parkinson's disease
  • SH-SY5Y

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment. / Hunya, Ákos; Földi, István; Szegedi, Viktor; Soós, K.; Zarándi, Márta; Szabó, Antal; Zádori, Dénes; Penke, B.; Datki, Zsolt L.

In: Brain Research Bulletin, Vol. 75, No. 5, 28.03.2008, p. 648-654.

Research output: Contribution to journalArticle

Hunya, Ákos ; Földi, István ; Szegedi, Viktor ; Soós, K. ; Zarándi, Márta ; Szabó, Antal ; Zádori, Dénes ; Penke, B. ; Datki, Zsolt L. / Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment. In: Brain Research Bulletin. 2008 ; Vol. 75, No. 5. pp. 648-654.
@article{729dbe472d654e84b63b913dbbbf8f26,
title = "Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment",
abstract = "Alpha-synuclein (αSN) plays a major role in numerous neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Intracellular inclusions containing aggregated αSN have been reported in Alzheimer's and Parkinson's affected brains. Moreover, a proteolytic fragment of αSN, the so-called non-amyloid component of Alzheimer's disease amyloid (NAC) was found to be an integral part of Alzheimer's dementia related plaques. Despite the extensive research on this topic, the exact toxic mechanism of αSN remains elusive. We have taken the advantage of an αSN overexpressing SH-SY5Y cell line and investigated the effects of classical apoptotic factors (e.g. H2O2, amphotericin B and ruthenium red) and aggregated disease-related peptides on cell viability compared to wild type neuroblastoma cells. It was found that αSN overexpressing cells are more sensitive to aggregated peptides treatment than normal expressing counterparts. In contrast, cells containing elevated amount of αSN were less vulnerable to classical apoptotic stressors than wild type cells. In addition, αSN overexpression is accompanied by altered phenotype, attenuated proliferation kinetics, increased neurite arborisation and decreased cell motility. Based on these results, the αSN overexpressing cell lines may represent a good and effective in vitro model for Alzheimer's and Parkinson's disease.",
keywords = "Alpha-synuclein, Alzheimer's disease, Beta-amyloid, NAC, Parkinson's disease, SH-SY5Y",
author = "{\'A}kos Hunya and Istv{\'a}n F{\"o}ldi and Viktor Szegedi and K. So{\'o}s and M{\'a}rta Zar{\'a}ndi and Antal Szab{\'o} and D{\'e}nes Z{\'a}dori and B. Penke and Datki, {Zsolt L.}",
year = "2008",
month = "3",
day = "28",
doi = "10.1016/j.brainresbull.2007.10.035",
language = "English",
volume = "75",
pages = "648--654",
journal = "Brain Research Bulletin",
issn = "0361-9230",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment

AU - Hunya, Ákos

AU - Földi, István

AU - Szegedi, Viktor

AU - Soós, K.

AU - Zarándi, Márta

AU - Szabó, Antal

AU - Zádori, Dénes

AU - Penke, B.

AU - Datki, Zsolt L.

PY - 2008/3/28

Y1 - 2008/3/28

N2 - Alpha-synuclein (αSN) plays a major role in numerous neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Intracellular inclusions containing aggregated αSN have been reported in Alzheimer's and Parkinson's affected brains. Moreover, a proteolytic fragment of αSN, the so-called non-amyloid component of Alzheimer's disease amyloid (NAC) was found to be an integral part of Alzheimer's dementia related plaques. Despite the extensive research on this topic, the exact toxic mechanism of αSN remains elusive. We have taken the advantage of an αSN overexpressing SH-SY5Y cell line and investigated the effects of classical apoptotic factors (e.g. H2O2, amphotericin B and ruthenium red) and aggregated disease-related peptides on cell viability compared to wild type neuroblastoma cells. It was found that αSN overexpressing cells are more sensitive to aggregated peptides treatment than normal expressing counterparts. In contrast, cells containing elevated amount of αSN were less vulnerable to classical apoptotic stressors than wild type cells. In addition, αSN overexpression is accompanied by altered phenotype, attenuated proliferation kinetics, increased neurite arborisation and decreased cell motility. Based on these results, the αSN overexpressing cell lines may represent a good and effective in vitro model for Alzheimer's and Parkinson's disease.

AB - Alpha-synuclein (αSN) plays a major role in numerous neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease. Intracellular inclusions containing aggregated αSN have been reported in Alzheimer's and Parkinson's affected brains. Moreover, a proteolytic fragment of αSN, the so-called non-amyloid component of Alzheimer's disease amyloid (NAC) was found to be an integral part of Alzheimer's dementia related plaques. Despite the extensive research on this topic, the exact toxic mechanism of αSN remains elusive. We have taken the advantage of an αSN overexpressing SH-SY5Y cell line and investigated the effects of classical apoptotic factors (e.g. H2O2, amphotericin B and ruthenium red) and aggregated disease-related peptides on cell viability compared to wild type neuroblastoma cells. It was found that αSN overexpressing cells are more sensitive to aggregated peptides treatment than normal expressing counterparts. In contrast, cells containing elevated amount of αSN were less vulnerable to classical apoptotic stressors than wild type cells. In addition, αSN overexpression is accompanied by altered phenotype, attenuated proliferation kinetics, increased neurite arborisation and decreased cell motility. Based on these results, the αSN overexpressing cell lines may represent a good and effective in vitro model for Alzheimer's and Parkinson's disease.

KW - Alpha-synuclein

KW - Alzheimer's disease

KW - Beta-amyloid

KW - NAC

KW - Parkinson's disease

KW - SH-SY5Y

UR - http://www.scopus.com/inward/record.url?scp=40749146428&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=40749146428&partnerID=8YFLogxK

U2 - 10.1016/j.brainresbull.2007.10.035

DO - 10.1016/j.brainresbull.2007.10.035

M3 - Article

C2 - 18355641

AN - SCOPUS:40749146428

VL - 75

SP - 648

EP - 654

JO - Brain Research Bulletin

JF - Brain Research Bulletin

SN - 0361-9230

IS - 5

ER -